Synergism between platelet-rich fibrin with superpulsed laser and pulsed magnetic field in the treatment of disc herniations: A therapeutic protocol v

Herniated discs affect about 1% to 5% of the general population and are more common in adults between the ages of 30 and 50 years, the peak of productive age. Among the risk factors are obesity, sedentary lifestyle and activities that involve weightlifting. This condition often results in chronic pain, depression, work disability, and reduced daily functional capacity. Clinically, patients present with localized pain with or without irradiation, muscle weakness, tingling, and, in more severe cases, loss of sensation. The definitive diagnosis is obtained through imaging tests, such as CT scans or MRIs, which allow confirmation of the extent and location of the hernia. Therapeutic options range from conservative approaches, including physical therapy and analgesic and anti-inflammatory medications, to surgical interventions for cases where there is significant neurological impairment. Recently, innovative therapies such as superpulsed laser, pulsed magnetic field, and Orthobiological, such as injectable platelet-rich fibrin, have shown promising results. The combination of orthobiologicals with superpulsed laser and pulsed magnetic field offers an integrated approach to modulate the inflammatory response and promote tissue regeneration. This therapeutic synergy can provide effective symptomatic relief, injured tissue repair, and accelerated recovery. The regenerative approach to herniated discs, which combines orthobiological, superpulsed laser, and pulsed magnetic field, has the potential to revolutionize treatment by offering a minimally invasive, safe, and effective option for patients. Additional studies are needed to evaluate the statistical effectiveness and side effects of this innovative approach.